IBP Stock +106.23% Since Nov ’07 Pick IBP Stock +106.23% Since Nov ’07 Pick Unlock Top Buy Picks

Range Low Price High Price Comment
30 days $2.35 $2.95 Monday, 15th Apr 2024 CLLS stock ended at $2.61. This is 2.97% less than the trading day before Friday, 12th Apr 2024. During the day the stock fluctuated 4.33% from a day low at $2.54 to a day high of $2.65.
90 days $2.35 $3.13
52 weeks $0.96 $3.77

Historical Cellectis S.A. prices

Date Open High Low Close Volume
2021-02-08 $28.00 $28.89 $27.56 $28.05 631 351
2021-02-05 $26.60 $26.60 $25.80 $26.49 359 582
2021-02-04 $24.61 $25.88 $24.01 $25.74 920 929
2021-02-03 $29.62 $30.00 $22.01 $22.94 2 294 216
2021-02-02 $29.44 $30.08 $28.78 $28.89 368 202
2021-02-01 $28.58 $28.87 $28.04 $28.44 314 439
2021-01-29 $28.24 $28.62 $26.70 $27.34 268 617
2021-01-28 $28.86 $30.16 $28.07 $28.25 251 549
2021-01-27 $29.10 $29.57 $27.31 $27.79 368 680
2021-01-26 $31.50 $32.25 $29.59 $30.11 222 956
2021-01-25 $30.75 $31.61 $30.05 $31.30 231 749
2021-01-22 $31.44 $32.05 $30.83 $31.27 249 305
2021-01-21 $33.43 $33.45 $31.30 $31.62 349 845
2021-01-20 $33.28 $34.71 $33.09 $33.09 619 297
2021-01-19 $34.09 $34.20 $32.71 $33.25 555 474
2021-01-15 $30.60 $32.60 $30.53 $30.91 594 095
2021-01-14 $29.47 $32.12 $29.47 $30.94 455 359
2021-01-13 $28.40 $31.16 $28.24 $29.26 426 084
2021-01-12 $27.63 $28.13 $27.52 $27.87 263 706
2021-01-11 $28.65 $28.98 $27.47 $27.54 384 823
2021-01-08 $29.57 $31.43 $29.50 $29.58 673 151
2021-01-07 $27.48 $29.56 $27.48 $28.95 451 766
2021-01-06 $27.05 $28.95 $27.05 $27.13 449 143
2021-01-05 $27.97 $28.04 $26.46 $27.18 276 543
2021-01-04 $28.02 $28.56 $26.96 $27.60 347 848
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis S.A. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT